SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-09-026328
Filing Date
2009-04-27
Accepted
2009-04-27 11:57:13
Documents
5
Effectiveness Date
2009-04-27

Document Format Files

Seq Description Document Type Size
1 DEFA14A a09-10836_2defa14a.htm DEFA14A 36154
2 GRAPHIC g108362bci001.jpg GRAPHIC 74515
3 GRAPHIC g108362bci002.gif GRAPHIC 77801
4 GRAPHIC g108362bci003.gif GRAPHIC 39517
5 GRAPHIC g108362bci004.gif GRAPHIC 47118
  Complete submission text file 0001104659-09-026328.txt   367502
Mailing Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069 8474780500
BIOSANTE PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-31812 | Film No.: 09771682
SIC: 2836 Biological Products, (No Diagnostic Substances)